Neglected infectious diseases: are push and pull incentive mechanisms suitable for promoting research?
Author
Abstract
Suggested Citation
Download full text from publisher
References listed on IDEAS
- Nancy Gallini & Suzanne Scotchmer, 2002.
"Intellectual Property: When Is It the Best Incentive System?,"
NBER Chapters, in: Innovation Policy and the Economy, Volume 2, pages 51-78,
National Bureau of Economic Research, Inc.
- Gallini, Nancy & Scotchmer, Suzanne, 2001. "Intellectual Property: When Is It the Best Incentive System?," Department of Economics, Working Paper Series qt9wx2c2hz, Department of Economics, Institute for Business and Economic Research, UC Berkeley.
- Nancy Gallini & Suzanne Scotchmer, 2003. "Intellectual Property: When is it the Best Incentive System?," Levine's Working Paper Archive 618897000000000532, David K. Levine.
- Nancy Gallini & Suzanne Scotchmer, 2002. "Intellectual Property: When Is It the Best Incentive System?," Law and Economics 0201001, University Library of Munich, Germany.
- Nancy Gallini and Suzanne Scotchmer., 2001. "Intellectual Property: When Is It the Best Incentive System?," Economics Working Papers E01-303, University of California at Berkeley.
- Mrazek, Monique F. & Mossialos, Elias, 2003. "Stimulating pharmaceutical research and development for neglected diseases," Health Policy, Elsevier, vol. 64(1), pages 75-88, April.
- Daron Acemoglu & Joshua Linn, 2004.
"Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 119(3), pages 1049-1090.
- Daron Acemoglu & Joshua Linn, 2003. "Market Size in Innovation: Theory and Evidence From the Pharmaceutical Industry," NBER Working Papers 10038, National Bureau of Economic Research, Inc.
- Daron Acemoglu & Joshua Linn, 2004. "Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry," Levine's Working Paper Archive 228400000000000002, David K. Levine.
- Ernst R. Berndt & Rachel Glennerster & Michael R. Kremer & Jean Lee & Ruth Levine & Georg Weizsäcker & Heidi Williams, 2007.
"Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness,"
Health Economics, John Wiley & Sons, Ltd., vol. 16(5), pages 491-511, May.
- Ernst R. Berndt & Rachel Glennerster & Michael Kremer & Jean Lee & Ruth Levine & Georg Weizsacker & Heidi Williams, 2006. "Advance Market Commitments for Vaccines Against Neglected Diseases: Estimating Costs and Effectiveness," CID Working Papers 127, Center for International Development at Harvard University.
- Harhoff, Dietmar & Scherer, Frederic M. & Vopel, Katrin, 2003. "Citations, family size, opposition and the value of patent rights," Research Policy, Elsevier, vol. 32(8), pages 1343-1363, September.
- Adam B. Jaffe & Josh Lerner & Scott Stern, 2001.
"Innovation Policy and the Economy, Volume 1,"
NBER Books,
National Bureau of Economic Research, Inc, number jaff01-1, March.
- Adam B. Jaffe & Josh Lerner & Scott Stern, 2001. "Innovation Policy and the Economy, Volume 1," MIT Press Books, The MIT Press, edition 1, volume 1, number 0262600412, December.
- Bronwyn H. Hall & John van Reenen, 1999. "How Effective are Fiscal Incentives for R&D? A New Review of the Evidence," NBER Working Papers 7098, National Bureau of Economic Research, Inc.
- Frank R. Lichtenberg & Joel Waldfogel, 2003. "Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act," NBER Working Papers 9750, National Bureau of Economic Research, Inc.
- Buckup, Sebastian, 2008. "Global public–private partnerships against neglected diseases: building governance structures for effective outcomes," Health Economics, Policy and Law, Cambridge University Press, vol. 3(1), pages 31-50, January.
- Lybecker, Kristina M. & Freeman, Robert A., 2007. "Funding pharmaceutical innovation through direct tax credits," Health Economics, Policy and Law, Cambridge University Press, vol. 2(3), pages 267-284, July.
- Adam B. Jaffe & Josh Lerner & Scott Stern, 2002. "Innovation Policy and the Economy, Volume 2," NBER Books, National Bureau of Economic Research, Inc, number jaff02-1, October.
- Michael Kremer & Heidi Williams, 2010.
"Incentivizing Innovation: Adding to the Tool Kit,"
NBER Chapters, in: Innovation Policy and the Economy, Volume 10, pages 1-17,
National Bureau of Economic Research, Inc.
- Michael Kremer & Heidi Williams, 2010. "Incentivizing Innovation: Adding to the Tool Kit," Innovation Policy and the Economy, University of Chicago Press, vol. 10(1), pages 1-17.
- Harhoff, Dietmar & Scherer, Frederic M. & Vopel, Katrin, 2004. "Erratum to "Citations, family size, opposition and the value of patent rights" [Research Policy 32 (2003) 1343-1363]," Research Policy, Elsevier, vol. 33(2), pages 363-364, March.
- DiMasi, Joseph A. & Hansen, Ronald W. & Grabowski, Henry G., 2003. "The price of innovation: new estimates of drug development costs," Journal of Health Economics, Elsevier, vol. 22(2), pages 151-185, March.
Citations
Blog mentions
As found by EconAcademics.org, the blog aggregator for Economics research:- How to encourage research into neglected diseases
by Economic Logician in Economic Logic on 2012-08-14 18:51:00
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Hoddinott, John F. & Gillespie, Stuart & Yosef, Sivan, 2015. "Public-private partnerships and the reduction of undernutrition in developing countries," IFPRI discussion papers 1487, International Food Policy Research Institute (IFPRI).
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Mueller-Langer, Frank, 2013. "Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research?," Health Economics, Policy and Law, Cambridge University Press, vol. 8(2), pages 185-208, April.
- Philippe Aghion & Antoine Dechezleprêtre & David Hémous & Ralf Martin & John Van Reenen, 2016.
"Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry,"
Journal of Political Economy, University of Chicago Press, vol. 124(1), pages 1-51.
- Aghion, Philippe & Dechezlepretre, Antoine & Hemous, David & Martin, Ralf & Van Reenen, John, 2012. "Carbon taxes, path dependency and directed technical change: evidence from the auto industry," LSE Research Online Documents on Economics 48936, London School of Economics and Political Science, LSE Library.
- Aghion, Philippe & Dechezlepretre, Antoine & Hemous, David & Martin, Ralf & Van Reenen, John, 2012. "Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry," Climate Change and Sustainable Development 143129, Fondazione Eni Enrico Mattei (FEEM).
- Philippe Aghion & Antoine Dechezleprêtre & David Hemous & Ralf Martin & John Van Reenen, 2012. "Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry," NBER Working Papers 18596, National Bureau of Economic Research, Inc.
- Philippe Aghion & Antoine Dechezleprêtre & David Hémous & Ralf Martin & John van Reenen, 2016. "Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry," PSE-Ecole d'économie de Paris (Postprint) halshs-01496920, HAL.
- Aghion, Philippe & Dechezlepretre, Antoine & Hemous, David & Martin, Ralf & Van Reenen, John, 2016. "Carbon taxes, path dependency and directed technical change: evidence from the auto industry," LSE Research Online Documents on Economics 62722, London School of Economics and Political Science, LSE Library.
- Aghion, Philippe & Van Reenen, John & Martin, Ralf & Hémous, David & Dechezleprêtre, Antoine, 2012. "Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry," CEPR Discussion Papers 9267, C.E.P.R. Discussion Papers.
- Philippe Aghion & Antoine Dechezleprêtre & David Hémous & Ralf Martin & John van Reenen, 2016. "Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry," Post-Print halshs-01496920, HAL.
- Philippe Aghion & Antoine Dechezleprêtre & David Hemous & Ralf Martin & John Van Reenen, 2012. "Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry," CEP Discussion Papers dp1178, Centre for Economic Performance, LSE.
- Aghion, Philippe & Dechezleprêtre, Antoine & Hemous, David & Martin, Ralf & Van Reenen, John, 2016. "Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry," Scholarly Articles 27759048, Harvard University Department of Economics.
- Philippe Aghion & Antoine Dechezleprêtre & David Hemous & Ralf Martin & John Van Reenen, 2012. "Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry," Working Papers 2012.99, Fondazione Eni Enrico Mattei.
- Philippe Aghion & Antoine Dechezlepr�tre & David Hemous & Ralf Martin & John Van Reenen, 2012. "Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry," GRI Working Papers 102, Grantham Research Institute on Climate Change and the Environment.
- Patricia M. Danzon & Eric L. Keuffel, 2014. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484, National Bureau of Economic Research, Inc.
- Brueggemann, Julia & Meub, Lukas, 2015. "Experimental evidence on the effects of innovation contests," University of Göttingen Working Papers in Economics 251, University of Goettingen, Department of Economics.
- Hémous, David & Dechezleprêtre, Antoine & Olsen, Morten & Zanella, carlo, 2019.
"Automating Labor: Evidence from Firm-level Patent Data,"
CEPR Discussion Papers
14249, C.E.P.R. Discussion Papers.
- Antoine Dechezleprêtre & David Hemous & Morten Olsen & Carlo Zanella, 2020. "Automating labor: evidence from firm-level patent data," CEP Discussion Papers dp1679.pdf, Centre for Economic Performance, LSE.
- Dechezlepretre, Antoine & Hemous, David & Olsen, Morten & Zanella, Carlo, 2020. "Automating labor: evidence from firm-level patent data," LSE Research Online Documents on Economics 108420, London School of Economics and Political Science, LSE Library.
- Bhaven Sampat & Heidi L. Williams, 2019.
"How Do Patents Affect Follow-On Innovation? Evidence from the Human Genome,"
American Economic Review, American Economic Association, vol. 109(1), pages 203-236, January.
- Bhaven Sampat & Heidi L. Williams, 2015. "How Do Patents Affect Follow-On Innovation? Evidence from the Human Genome," NBER Working Papers 21666, National Bureau of Economic Research, Inc.
- Gamba, Simona, 2017.
"The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector,"
World Development, Elsevier, vol. 99(C), pages 15-27.
- Simona Gamba, 2016. "The effect of Intellectual Property Rights on domestic innovation in the pharmaceutical sector," FBK-IRVAPP Working Papers 2016-05, Research Institute for the Evaluation of Public Policies (IRVAPP), Bruno Kessler Foundation.
- Simona Gamba, 2016. "The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector," CESifo Working Paper Series 6004, CESifo.
- Agarwal, Ruchir & Gaule, Patrick, 2022.
"What drives innovation? Lessons from COVID-19 R&D,"
Journal of Health Economics, Elsevier, vol. 82(C).
- Ruchir Agarwal & Patrick Gaulé, 2021. "What Drives Innovation? Lessons from COVID-19 R&D," IMF Working Papers 2021/048, International Monetary Fund.
- Agarwal, Ruchir & Gaule, Patrick, 2021. "What Drives Innovation? Lessons from COVID-19 R&D," IZA Discussion Papers 14079, Institute of Labor Economics (IZA).
- Martin, Ralf & Thomas, Catherine & Mohnen, Pierre & Verhoeven, Dennis & Guillard, Charlotte, 2021.
"Efficient Industrial Policy for Innovation: Standing on the shoulders of Hidden Giants,"
CEPR Discussion Papers
16850, C.E.P.R. Discussion Papers.
- Charlotte Guillard & Ralf Martin & Pierre Mohnen & Catherine Thomas & Dennis Verhoeven, 2022. "Efficient industrial policy for innovation: standing on the shoulders of hidden giants," POID Working Papers 054, Centre for Economic Performance, LSE.
- Guillard, Charlotte & Martin, Ralf & Thomas, Catherine & Verhoeven, Dennis, 2021. "Efficient industrial policy for innovation: standing on the shoulders of hidden giants," LSE Research Online Documents on Economics 113832, London School of Economics and Political Science, LSE Library.
- Charlotte Guillard & Ralf Martin & Pierre Mohnen & Catherine Thomas & Dennis Verhoeven, 2021. "Efficient industrial policy for innovation: standing on the shoulders of hidden giants," CEP Discussion Papers dp1813, Centre for Economic Performance, LSE.
- Cesare Righi & Timothy Simcoe, 2022. "Patenting inventions or inventing patents? Continuation practice at the USPTO," Economics Working Papers 1820, Department of Economics and Business, Universitat Pompeu Fabra.
- Wagner, Stefan & Wakeman, Simon, 2016.
"What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry,"
Research Policy, Elsevier, vol. 45(5), pages 1091-1102.
- Stefan Wagner & Simon Wakeman, 2014. "What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry," ESMT Research Working Papers ESMT-14-01 (R1), ESMT European School of Management and Technology, revised 09 Mar 2015.
- Michael Kremer & Jonathan Levin & Christopher M. Snyder, 2022.
"Designing Advance Market Commitments for New Vaccines,"
Management Science, INFORMS, vol. 68(7), pages 4786-4814, July.
- Michael Kremer & Jonathan D. Levin & Christopher M. Snyder, 2020. "Designing Advance Market Commitments for New Vaccines," Working Papers 2020-175, Becker Friedman Institute for Research In Economics.
- Michael Kremer & Jonathan D. Levin & Christopher M. Snyder, 2020. "Designing Advance Market Commitments for New Vaccines," NBER Working Papers 28168, National Bureau of Economic Research, Inc.
- Dekker, Thijs & Vollebergh, Herman R.J. & de Vries, Frans P. & Withagen, Cees A., 2012. "Inciting protocols," Journal of Environmental Economics and Management, Elsevier, vol. 64(1), pages 45-67.
- Yin, Wesley, 2008. "Market incentives and pharmaceutical innovation," Journal of Health Economics, Elsevier, vol. 27(4), pages 1060-1077, July.
- Angelo Kenneth S. Romasanta & Peter Sijde & Jacqueline Muijlwijk-Koezen, 2020. "Innovation in pharmaceutical R&D: mapping the research landscape," Scientometrics, Springer;Akadémiai Kiadó, vol. 125(3), pages 1801-1832, December.
- Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2009. "Nuove politiche per l'innovazione nel settore delle scienze della vita," Working Papers CERM 03-2009, Competitività, Regole, Mercati (CERM).
- Kalcheva, Ivalina & McLemore, Ping & Pant, Shagun, 2018. "Innovation: The interplay between demand-side shock and supply-side environment," Research Policy, Elsevier, vol. 47(2), pages 440-461.
- Thijs Dekker & Herman R.J. Vollebergh & Frans P. de Vries & Cees A. Withagen, 2009. "Inciting Protocols - How International Environmental Agreements Trigger Knowledge Transfers," Tinbergen Institute Discussion Papers 09-060/3, Tinbergen Institute, revised 29 Nov 2010.
- Adrian Towse, 2007. "If it ain't broke, don't price fix it: the OFT and the PPRS," Health Economics, John Wiley & Sons, Ltd., vol. 16(7), pages 653-665, July.
- Giuliani, Elisa & Martinelli, Arianna & Rabellotti, Roberta, 2016.
"Is Co-Invention Expediting Technological Catch Up? A Study of Collaboration between Emerging Country Firms and EU Inventors,"
World Development, Elsevier, vol. 77(C), pages 192-205.
- Giuliani , Elisa & Martinelli , Arianna & Rabellotti , Roberta, 2014. "Is Co-Invention Expediting Technological Catch Up? A Study of Collaboration between Emerging Country Firms and EU inventors," Papers in Innovation Studies 2014/25, Lund University, CIRCLE - Centre for Innovation Research.
- Elisa Giuliani & Arianna Martinelli & Roberta Rabellotti, 2015. "Is Co-Invention Expediting Technological Catch Up? A Study of Collaboration between Emerging Country Firms and EU inventors," LEM Papers Series 2015/10, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
More about this item
Keywords
Neglected infectious diseases; Research and Development; push incentive mechanisms; pull incentive mechanisms;All these keywords.
JEL classification:
- I12 - Health, Education, and Welfare - - Health - - - Health Behavior
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
- L3 - Industrial Organization - - Nonprofit Organizations and Public Enterprise
- O31 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Innovation and Invention: Processes and Incentives
NEP fields
This paper has been announced in the following NEP Reports:- NEP-HEA-2012-07-29 (Health Economics)
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pra:mprapa:40193. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Joachim Winter (email available below). General contact details of provider: https://edirc.repec.org/data/vfmunde.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.